{"id":329427,"date":"2026-10-28T10:22:24","date_gmt":"2026-10-28T04:52:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=329427"},"modified":"2026-10-28T10:22:24","modified_gmt":"2026-10-28T04:52:24","slug":"midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Revenue Growth 10-20 Per Cent Stocks to Watch for Future Multibagger Potential: Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Uno Minda Rs 1,085. Nippon Life India AMC Rs 933.50. Ajanta Pharma Rs 3,353.60. Patanjali Foods Rs 347.95. Market caps from Rs 38,271 crore to Rs 65,032 crore. Data as of 27 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods are the 4 picks in this revenue growth 10-20 per cent stocks watchlist, with market caps between Rs 38,271 crore and Rs 65,032 crore. Uno Minda stands out for the fastest profit growth, 38.65% a year since FY22, while Nippon Life India AMC offers the highest return on equity at 32.83%. PE ratios run from 19.43 to 50.38, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.<\/p>\n<\/p><\/div>\n<p>Revenue growth 10-20 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods meet that test, with market caps from Rs 38,271 crore to Rs 65,032 crore and Uno Minda offering the fastest profit growth, 38.65% a year since FY22. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 revenue growth between 10 and 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 revenue growth between 10 and 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening revenue growth 10-20 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=revenue-growth-per-cent-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#What_Are_Revenue_Growth_10-20_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?\">What Are Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Revenue_Growth_10-20_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE\">Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Uno_Minda_3865_Profit_CAGR_Since_FY22\" title=\"Uno Minda: 38.65% Profit CAGR Since FY22\">Uno Minda: 38.65% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Nippon_Life_India_AMC_Return_on_Equity_of_3283\" title=\"Nippon Life India AMC: Return on Equity of 32.83%\">Nippon Life India AMC: Return on Equity of 32.83%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Ajanta_Pharma_Return_on_Equity_of_2333\" title=\"Ajanta Pharma: Return on Equity of 23.33%\">Ajanta Pharma: Return on Equity of 23.33%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Patanjali_Foods_Quarterly_Profit_Up_8614\" title=\"Patanjali Foods: Quarterly Profit Up 86.14%\">Patanjali Foods: Quarterly Profit Up 86.14%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Revenue_Growth_10-20_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins\">Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Uno_Minda_Nippon_Life_India_AMC_Ajanta_Pharma_and_Patanjali_Foods\" title=\"Institutional Holding in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods\">Institutional Holding in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Revenue_Growth_10-20_Per_Cent_Stocks\" title=\"Risks to Weigh in Revenue Growth 10-20 Per Cent Stocks\">Risks to Weigh in Revenue Growth 10-20 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Revenue_Growth_10-20_Per_Cent_Stocks\" title=\"How to Choose Between Revenue Growth 10-20 Per Cent Stocks\">How to Choose Between Revenue Growth 10-20 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Revenue_Growth_10-20_Per_Cent_Stocks_to_Watch\" title=\"Frequently Asked Questions on Revenue Growth 10-20 Per Cent Stocks to Watch\">Frequently Asked Questions on Revenue Growth 10-20 Per Cent Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Which_are_the_best_revenue_growth_10-20_per_cent_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best revenue growth 10-20 per cent stocks to watch for multibagger potential?\">Which are the best revenue growth 10-20 per cent stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Is_Nippon_Life_India_AMC_a_good_stock_for_long-term_investors\" title=\"Is Nippon Life India AMC a good stock for long-term investors?\">Is Nippon Life India AMC a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Can_Uno_Minda_become_a_multibagger_from_here\" title=\"Can Uno Minda become a multibagger from here?\">Can Uno Minda become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Uno_Minda_Nippon_Life_India_AMC_Ajanta_Pharma_and_Patanjali_Foods\" title=\"What is the market cap of Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?\">What is the market cap of Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_revenue_growth_10-20_per_cent_stocks\" title=\"What are the risks of investing in revenue growth 10-20 per cent stocks?\">What are the risks of investing in revenue growth 10-20 per cent stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Why_is_Nippon_Life_India_AMC_trading_at_a_PE_of_3965\" title=\"Why is Nippon Life India AMC trading at a PE of 39.65?\">Why is Nippon Life India AMC trading at a PE of 39.65?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Uno_Minda_Nippon_Life_India_AMC_Ajanta_Pharma_and_Patanjali_Foods\" title=\"How much do institutions hold in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?\">How much do institutions hold in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Revenue_Growth_10-20_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Revenue growth 10-20 per cent stocks are shares of mid sized companies whose sales grew by 10 to 20 per cent in FY26, a pace that is fast enough to build value and steady enough to sustain. The four here cover auto components, asset management, pharmaceuticals and packaged foods.<\/p>\n<p>Sales growth in this range shows steady demand for a company products, and it gives profit a solid base to grow from. Within revenue growth 10-20 per cent stocks, the four companies show rising profit. For revenue growth 10-20 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read revenue growth 10-20 per cent stocks, the common thread is rising profit backed by complete financial data. With revenue growth 10-20 per cent stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for revenue growth 10-20 per cent stocks are complete. Read each company&#8217;s latest results and exchange filings before acting on revenue growth 10-20 per cent stocks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Revenue_Growth_10-20_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 27 October 2026. Patanjali Foods has the lowest PE of the group at 19.43, while Nippon Life India AMC posts the highest return on equity at 32.83%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/unominda\/uno-minda-ltd-share-price-today\">Uno Minda<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,085<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">65,032<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">50.38<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.22<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">994.00 to 1,355.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nam\/nippon-life-india-asset-management-ltd-share-price-today\">Nippon Life India Asset Management<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">933.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">64,905<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">39.65<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.02<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">795.80 to 1,269.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,353.60<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42,214<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.33%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,380.20 to 3,796.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/patanjali\/patanjali-foods-ltd-share-price-today\">Patanjali Foods<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">347.95<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">38,271<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.43<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.68<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.37%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.21<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">328.20 to 614.05<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Uno_Minda_3865_Profit_CAGR_Since_FY22\"><\/span><strong>Uno Minda: 38.65% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Uno Minda makes switches, lighting, sensors and safety components for two-wheeler, passenger and commercial vehicle makers. It reported FY26 revenue of Rs 19,692.02 crore, up 17.19% year on year, and net profit of Rs 1,284.06 crore, up 25.82%. Net profit has compounded at 38.65% a year since FY22, while revenue has grown 23.83% a year. Operating margin was 12.75% in FY26. The debt-to-equity ratio is 0.40.<\/p>\n<p>In the June 2026 quarter, revenue rose 23.60% to Rs 5,563.16 crore and net profit grew 2.10% to Rs 315.51 crore. The share price has gained 187.71% over five years. Domestic institutions raised their holding from 15.85% in June 2025 to 17.53% in June 2026. The stock trades at a PE of 50.38 against an industry PE of 37.22, with a return on equity of 17.53%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nippon_Life_India_AMC_Return_on_Equity_of_3283\"><\/span><strong>Nippon Life India AMC: Return on Equity of 32.83%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nippon Life India Asset Management is one of the largest mutual fund houses in India and also runs ETFs and portfolio management services. It reported FY26 revenue of Rs 2,933.07 crore, up 16.36% year on year, and net profit of Rs 1,528.13 crore, up 18.85%. Net profit has compounded at 19.74% a year since FY22, while revenue has grown 17.56% a year. Operating margin was 68.84% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 39.65 against an industry PE of 17.70, with a return on equity of 32.83%. The dividend yield is 2.11%. In the June 2026 quarter, revenue rose 24.51% to Rs 937.08 crore and net profit grew 27.15% to Rs 503.09 crore. The share price has gained 131.06% over five years and 20.07% over the past year. Domestic institutions raised their holding from 13.45% in June 2025 to 15.49% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ajanta_Pharma_Return_on_Equity_of_2333\"><\/span><strong>Ajanta Pharma: Return on Equity of 23.33%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026. The stock trades at a PE of 37.20 against an industry PE of 36.35, with a return on equity of 23.33%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Patanjali_Foods_Quarterly_Profit_Up_8614\"><\/span><strong>Patanjali Foods: Quarterly Profit Up 86.14%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Patanjali Foods refines and sells edible oils and food products under brands such as Ruchi Gold and also runs an oil palm business. It reported FY26 revenue of Rs 40,347.78 crore, up 19.05% year on year, and net profit of Rs 1,814.47 crore, up 39.50%. Operating margin was 4.83% in FY26. The debt-to-equity ratio is 0.21.<\/p>\n<p>The stock trades at a PE of 19.43 against an industry PE of 34.68, below the sector average, with a return on equity of 15.37%. In the June 2026 quarter, revenue rose 29.19% to Rs 11,341.89 crore and net profit grew 86.14% to Rs 335.73 crore. Domestic institutions raised their holding from 11.85% in September 2025 to 12.51% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Revenue_Growth_10-20_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these revenue growth 10-20 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Uno Minda<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19,692.02<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,284.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.82%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nippon Life India AMC<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,933.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,528.13<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.51%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.85%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">88.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Ajanta Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,624.93<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,056<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.60%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.73%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Patanjali Foods<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">40,347.78<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,814.47<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.05%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">39.50%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.83%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these revenue growth 10-20 per cent stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Uno_Minda_Nippon_Life_India_AMC_Ajanta_Pharma_and_Patanjali_Foods\"><\/span><strong>Institutional Holding in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these revenue growth 10-20 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Ajanta Pharma has the deepest institutional backing, with FII and DII together holding 29.57% as of September 2026. Domestic institutions increased their holding over the past year in Uno Minda (from 15.85% to 17.53%), Nippon Life India AMC (from 13.45% to 15.49%), Ajanta Pharma (from 17.90% to 21.94%) and Patanjali Foods (from 11.85% to 12.51%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Uno Minda<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nippon Life India AMC<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">71.80%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.04%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.49%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.67%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Ajanta Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">63.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.63%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.94%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Patanjali Foods<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68.25%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.51%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Revenue_Growth_10-20_Per_Cent_Stocks\"><\/span><strong>Risks to Weigh in Revenue Growth 10-20 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with revenue growth 10-20 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Nippon Life India AMC trades at a PE of 39.65 against an industry PE of 17.70, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Revenue_Growth_10-20_Per_Cent_Stocks\"><\/span><strong>How to Choose Between Revenue Growth 10-20 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from revenue growth 10-20 per cent stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (17.70 to 37.22) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among revenue growth 10-20 per cent stocks, Uno Minda stands out for the fastest profit growth, 38.65% a year since FY22, Nippon Life India AMC for the highest return on equity at 32.83%, Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06 and Patanjali Foods for the strongest latest-quarter profit growth at 86.14%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing revenue growth 10-20 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Revenue_Growth_10-20_Per_Cent_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Revenue Growth 10-20 Per Cent Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_revenue_growth_10-20_per_cent_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best revenue growth 10-20 per cent stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods are the 4 names this list highlights, with market caps of Rs 65,032 crore, Rs 64,905 crore, Rs 42,214 crore and Rs 38,271 crore respectively. Uno Minda is notable for the fastest profit growth, 38.65% a year since FY22. Nippon Life India AMC stands out for the highest return on equity at 32.83%. Ajanta Pharma offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Patanjali Foods brings the strongest latest-quarter profit growth at 86.14%. These are watchlist names for revenue growth 10-20 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Nippon_Life_India_AMC_a_good_stock_for_long-term_investors\"><\/span><strong>Is Nippon Life India AMC a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nippon Life India AMC has a return on equity of 32.83%, a PE of 39.65 against an industry PE of 17.70 and a market cap of Rs 64,905 crore. Net profit has compounded at 19.74% a year since FY22, and FY26 revenue rose 16.36% while June 2026 quarter net profit grew 27.15%. Long-term returns in revenue growth 10-20 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Uno_Minda_become_a_multibagger_from_here\"><\/span><strong>Can Uno Minda become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in revenue growth 10-20 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 50.38 against an industry PE of 37.22, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Uno_Minda_Nippon_Life_India_AMC_Ajanta_Pharma_and_Patanjali_Foods\"><\/span><strong>What is the market cap of Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 27 October 2026, Uno Minda has a market cap of Rs 65,032 crore, Nippon Life India AMC has a market cap of Rs 64,905 crore, Ajanta Pharma has a market cap of Rs 42,214 crore and Patanjali Foods has a market cap of Rs 38,271 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on revenue growth 10-20 per cent stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_revenue_growth_10-20_per_cent_stocks\"><\/span><strong>What are the risks of investing in revenue growth 10-20 per cent stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Nippon Life India AMC trades at a PE of 39.65 against an industry PE of 17.70, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Nippon_Life_India_AMC_trading_at_a_PE_of_3965\"><\/span><strong>Why is Nippon Life India AMC trading at a PE of 39.65?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nippon Life India AMC&#8217;s PE of 39.65 compares with an industry PE of 17.70. The market is paying a premium for a return on equity of 32.83%, profit growth of 19.74% a year since FY22 and latest-quarter profit growth of 27.15%, which also means the stock is more sensitive if growth slows. Investors in revenue growth 10-20 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Uno_Minda_Nippon_Life_India_AMC_Ajanta_Pharma_and_Patanjali_Foods\"><\/span><strong>How much do institutions hold in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 25.68% of Uno Minda (8.15% and 17.53%), 22.53% of Nippon Life India AMC (7.04% and 15.49%), 29.57% of Ajanta Pharma (7.63% and 21.94%) and 19.75% of Patanjali Foods (7.24% and 12.51%). Rising institutional holding is a useful signal in revenue growth 10-20 per cent stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best revenue growth 10-20 per cent stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods are the 4 names this list highlights, with market caps of Rs 65,032 crore, Rs 64,905 crore, Rs 42,214 crore and Rs 38,271 crore respectively. Uno Minda is notable for the fastest profit growth, 38.65% a year since FY22. Nippon Life India AMC stands out for the highest return on equity at 32.83%. Ajanta Pharma offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Patanjali Foods brings the strongest latest-quarter profit growth at 86.14%. These are watchlist names for revenue growth 10-20 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Nippon Life India AMC a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nippon Life India AMC has a return on equity of 32.83%, a PE of 39.65 against an industry PE of 17.70 and a market cap of Rs 64,905 crore. Net profit has compounded at 19.74% a year since FY22, and FY26 revenue rose 16.36% while June 2026 quarter net profit grew 27.15%. Long-term returns in revenue growth 10-20 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Uno Minda become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in revenue growth 10-20 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 50.38 against an industry PE of 37.22, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 27 October 2026, Uno Minda has a market cap of Rs 65,032 crore, Nippon Life India AMC has a market cap of Rs 64,905 crore, Ajanta Pharma has a market cap of Rs 42,214 crore and Patanjali Foods has a market cap of Rs 38,271 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on revenue growth 10-20 per cent stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in revenue growth 10-20 per cent stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Nippon Life India AMC trades at a PE of 39.65 against an industry PE of 17.70, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Nippon Life India AMC trading at a PE of 39.65?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nippon Life India AMC's PE of 39.65 compares with an industry PE of 17.70. The market is paying a premium for a return on equity of 32.83%, profit growth of 19.74% a year since FY22 and latest-quarter profit growth of 27.15%, which also means the stock is more sensitive if growth slows. Investors in revenue growth 10-20 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 25.68% of Uno Minda (8.15% and 17.53%), 22.53% of Nippon Life India AMC (7.04% and 15.49%), 29.57% of Ajanta Pharma (7.63% and 21.94%) and 19.75% of Patanjali Foods (7.24% and 12.51%). Rising institutional holding is a useful signal in revenue growth 10-20 per cent stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap revenue growth 10-20 per cent stocks compared on market cap, PE, ROE, growth and institutional holding: Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods.<\/p>\n","protected":false},"author":33,"featured_media":329425,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[16946,16947],"class_list":["post-329427","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-revenue-growth-10-20-per-cent-stocks","tag-revenue-growth-between-10-and-20-per-cent-sector"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["329425"],"rank_math_title":["Revenue Growth 10-20 Per Cent Stocks to Watch in 2026"],"rank_math_description":["Revenue growth 10-20 per cent stocks to watch for multibagger potential: Uno Minda, Nippon Life India AMC, Ajanta Pharma and Patanjali Foods. Compare PE, ROE and growth."],"rank_math_focus_keyword":["revenue growth 10-20 per cent stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-revenue-growth-10-20-per-cent-stocks-to-watch-for-future-multibagger.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=329427"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329427\/revisions"}],"predecessor-version":[{"id":329428,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329427\/revisions\/329428"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/329425"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=329427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=329427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=329427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}